Caseware UK (AP4) 2022.0.179 2022.0.179 2023-02-282023-02-28truefalsefalse2022-03-01Radiology services11The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 12450037 2022-03-01 2023-02-28 12450037 2021-03-01 2022-02-28 12450037 2023-02-28 12450037 2022-02-28 12450037 c:Director1 2022-03-01 2023-02-28 12450037 c:RegisteredOffice 2022-03-01 2023-02-28 12450037 d:MotorVehicles 2022-03-01 2023-02-28 12450037 d:MotorVehicles 2023-02-28 12450037 d:MotorVehicles 2022-02-28 12450037 d:MotorVehicles d:OwnedOrFreeholdAssets 2022-03-01 2023-02-28 12450037 d:OfficeEquipment 2022-03-01 2023-02-28 12450037 d:OfficeEquipment 2023-02-28 12450037 d:OfficeEquipment 2022-02-28 12450037 d:OfficeEquipment d:OwnedOrFreeholdAssets 2022-03-01 2023-02-28 12450037 d:OwnedOrFreeholdAssets 2022-03-01 2023-02-28 12450037 d:CurrentFinancialInstruments 2023-02-28 12450037 d:CurrentFinancialInstruments 2022-02-28 12450037 d:CurrentFinancialInstruments d:WithinOneYear 2023-02-28 12450037 d:CurrentFinancialInstruments d:WithinOneYear 2022-02-28 12450037 d:ShareCapital 2023-02-28 12450037 d:ShareCapital 2022-02-28 12450037 d:RevaluationReserve 2023-02-28 12450037 d:RevaluationReserve 2022-02-28 12450037 d:OtherMiscellaneousReserve 2022-03-01 2023-02-28 12450037 d:RetainedEarningsAccumulatedLosses 2022-03-01 2023-02-28 12450037 d:RetainedEarningsAccumulatedLosses 2023-02-28 12450037 d:RetainedEarningsAccumulatedLosses 2022-02-28 12450037 c:OrdinaryShareClass1 2022-03-01 2023-02-28 12450037 c:OrdinaryShareClass1 2023-02-28 12450037 c:OrdinaryShareClass1 2022-02-28 12450037 c:OrdinaryShareClass2 2022-03-01 2023-02-28 12450037 c:OrdinaryShareClass2 2023-02-28 12450037 c:OrdinaryShareClass2 2022-02-28 12450037 c:OrdinaryShareClass3 2022-03-01 2023-02-28 12450037 c:OrdinaryShareClass3 2023-02-28 12450037 c:OrdinaryShareClass3 2022-02-28 12450037 c:OrdinaryShareClass4 2022-03-01 2023-02-28 12450037 c:OrdinaryShareClass4 2023-02-28 12450037 c:OrdinaryShareClass4 2022-02-28 12450037 c:OrdinaryShareClass5 2022-03-01 2023-02-28 12450037 c:OrdinaryShareClass5 2023-02-28 12450037 c:OrdinaryShareClass5 2022-02-28 12450037 c:FRS102 2022-03-01 2023-02-28 12450037 c:AuditExemptWithAccountantsReport 2022-03-01 2023-02-28 12450037 c:FullAccounts 2022-03-01 2023-02-28 12450037 c:PrivateLimitedCompanyLtd 2022-03-01 2023-02-28 12450037 d:EntityControlledByKeyManagementPersonnel1 2022-03-01 2023-02-28 12450037 d:EntityControlledByKeyManagementPersonnel1 2023-02-28 12450037 2 2022-03-01 2023-02-28 12450037 6 2022-03-01 2023-02-28 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 12450037









APPLIED RADIOLOGIC LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 28 FEBRUARY 2023

 
APPLIED RADIOLOGIC LIMITED
 
 
COMPANY INFORMATION


Director
Dr D S Levine 




Registered number
12450037



Registered office
7 The Close

Norwich

Norfolk

NR1 4DJ




Accountants
MA Partners LLP
Chartered Accountants

7 The Close

Norwich

Norfolk

NR1 4DJ





 
APPLIED RADIOLOGIC LIMITED
 

CONTENTS



Page
Accountants' report
 
 
1
Balance sheet
 
 
2 - 3
Notes to the financial statements
 
 
4 - 8


 
APPLIED RADIOLOGIC LIMITED
 
 
  
CHARTERED ACCOUNTANTS' REPORT TO THE DIRECTOR ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF APPLIED RADIOLOGIC LIMITED
FOR THE YEAR ENDED 28 FEBRUARY 2023

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Applied Radiologic Limited for the year ended 28 February 2023 which comprise  the Balance sheet and the related notes from the Company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW)we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com /regulation.

This report is made solely to the director of Applied Radiologic Limited in accordance with the terms of our engagement letter dated 10 February 2020Our work has been undertaken solely to prepare for your approval the financial statements of Applied Radiologic Limited  and state those matters that we have agreed to state to the director of Applied Radiologic Limited in this report in accordance with ICAEW Technical Release TECH07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Applied Radiologic Limited and its director for our work or for this report. 

It is your duty to ensure that Applied Radiologic Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Applied Radiologic Limited. You consider that Applied Radiologic Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or review of the financial statements of Applied Radiologic Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

  





MA Partners LLP
 
Chartered Accountants
  
7 The Close
Norwich
Norfolk
NR1 4DJ

25 September 2023
Page 1

 
APPLIED RADIOLOGIC LIMITED
REGISTERED NUMBER: 12450037

BALANCE SHEET
AS AT 28 FEBRUARY 2023

2023
2022
Note
£
£

Fixed assets
  

Tangible assets
 4 
2,722
3,566

Investments
 5 
101,633
-

  
104,355
3,566

Current assets
  

Debtors: amounts falling due within one year
 6 
11,523
7,463

Cash at bank and in hand
  
44,530
98,008

  
56,053
105,471

Creditors: amounts falling due within one year
 7 
(20,625)
(18,800)

Net current assets
  
 
 
35,428
 
 
86,671

Total assets less current liabilities
  
139,783
90,237

Provisions for liabilities
  

Deferred tax
  
(964)
(642)

  
 
 
(964)
 
 
(642)

Net assets
  
138,819
89,595


Capital and reserves
  

Called up share capital 
  
50
50

Other reserves
 9 
1,564
-

Profit and loss account
 9 
137,205
89,545

  
138,819
89,595


Page 2

 
APPLIED RADIOLOGIC LIMITED
REGISTERED NUMBER: 12450037
    
BALANCE SHEET (CONTINUED)
AS AT 28 FEBRUARY 2023

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 25 September 2023.






Dr D S Levine
Director

The notes on pages 4 to 8 form part of these financial statements.

Page 3

 
APPLIED RADIOLOGIC LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2023

1.


General information

The Company is a private company limited by shares.  It is both incorporated and domiciled in England and Wales.  The address of its registered office is 7 The Close, Norwich, NR1 4DJ.
The company's principal place of business is London and the company's principal activity is that of radiology services.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is measured at the fair value of the consideration received or receivable.  Revenue for radiology services is recognised in the period in which the services are provided.

 
2.3

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

 
2.4

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.5

Current and deferred taxation

The tax expense for the year comprises current and deferred tax.  
Deferred tax balances are recognised in respect of timing differences that have originated but not reversed by the balance sheet date.
The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

 
2.6

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 4

 
APPLIED RADIOLOGIC LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2023

2.Accounting policies (continued)


2.6
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using both the straight-line method and reducing balance basis.

Depreciation is provided on the following basis:

Motor vehicles
-
25%
reducing balance
Office equipment
-
25%
straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.7

Valuation of investments

Investments in listed company shares are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in profit or loss for the period.

 
2.8

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.9

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.10

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.11

Financial instruments

Investments in non-derivative instruments that are equity to the issuer are measured:
at fair value with changes recognised in the Profit and loss account if the shares are publicly traded or their fair value can otherwise be measured reliably;
at cost less impairment for all other investments.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Profit and loss account.

Page 5

 
APPLIED RADIOLOGIC LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2023

2.Accounting policies (continued)


2.11
Financial instruments (continued)

For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate of the recoverable amount, which is an approximation of the amount that the Company would receive for the asset if it were to be sold at the balance sheet date.


3.


Employees

The average monthly number of employees, including directors, during the year was 1 (2022 - 1).


4.


Tangible fixed assets





Motor vehicles
Office equipment
Total

£
£
£



Cost or valuation


At 1 March 2022
532
4,691
5,223


Additions
-
573
573



At 28 February 2023

532
5,264
5,796



Depreciation


At 1 March 2022
133
1,525
1,658


Charge for the year on owned assets
100
1,316
1,416



At 28 February 2023

233
2,841
3,074



Net book value



At 28 February 2023
299
2,423
2,722



At 28 February 2022
399
3,167
3,566

Page 6

 
APPLIED RADIOLOGIC LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2023

5.


Fixed asset investments





Listed investments

£



Cost or valuation


Additions
99,757


Disposals
(92)


Revaluations
1,968



At 28 February 2023
101,633





6.


Debtors

2023
2022
£
£


Trade debtors
10,750
6,330

Prepayments and accrued income
773
1,133

11,523
7,463



7.


Creditors: Amounts falling due within one year

2023
2022
£
£

Corporation tax
12,238
12,684

Other creditors
5,676
4,355

Accruals and deferred income
2,711
1,761

20,625
18,800


Page 7

 
APPLIED RADIOLOGIC LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2023

8.


Share capital

2023
2022
£
£
Allotted, called up and fully paid



1 (2022 - 1) Ordinary A share of £10
10
10
1 (2022 - 1) Ordinary B share of £10
10
10
1 (2022 - 1) Ordinary C share of £10
10
10
1 (2022 - 1) Ordinary D share of £10
10
10
1 (2022 - 1) Ordinary E share of £10
10
10

50

50



9.


Reserves

Other reserves

The fair value reserve represents the cumulative value of revaluations of the company's unlisted investments to fair value.  The amounts debited or credited to the reserve are transfers from the profit and loss account.  

Profit and loss account

The profit and loss account includes all current and prior period retained profits and losses.


10.Commitments, guarantees and contingencies

At 28 February 2023, the company had total financial commitments, guarantees and contingencies which are not included in the balance sheet amounting to £16,782.


11.


Related party transactions

As at 28 February 2023 the company owed the director £5,676 (2022: £4,355).

 
Page 8